Pharma Equity Group A/S
CSE:PEG

Watchlist Manager
Pharma Equity Group A/S Logo
Pharma Equity Group A/S
CSE:PEG
Watchlist
Price: 0.0972 DKK -2.8% Market Closed
Market Cap: 119.3m DKK

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of PEG.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PEG Intrinsic Value
Not Available
Base Case Scenario
Compare PEG to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PEG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharma Equity Group A/S

Current Assets 61.7m
Cash & Short-Term Investments 702k
Receivables 60m
Other Current Assets 921k
Non-Current Assets 646k
PP&E 144k
Other Non-Current Assets 502k
Current Liabilities 7.7m
Accounts Payable 3.9m
Short-Term Debt 127k
Other Current Liabilities 3.7m
Non-Current Liabilities 15.2m
Long-Term Debt 15.2m
Efficiency

Free Cash Flow Analysis
Pharma Equity Group A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pharma Equity Group A/S

Revenue
0 DKK
Operating Expenses
-18m DKK
Operating Income
-18m DKK
Other Expenses
-2.8m DKK
Net Income
-20.9m DKK
Fundamental Scores

PEG Profitability Score
Profitability Due Diligence

Pharma Equity Group A/S's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Pharma Equity Group A/S's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

PEG Solvency Score
Solvency Due Diligence

Pharma Equity Group A/S's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
64/100
Solvency
Score

Pharma Equity Group A/S's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PEG Price Targets Summary
Pharma Equity Group A/S

There are no price targets for PEG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Pharma Equity Group A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for PEG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y